Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01507155 · ClinicalTrials.gov registry record · NA
An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay
A NA study, sponsored by Genomind.
- Completed
- Registry status
- NA
- Development phase
- 685
- Enrollment target
NCT01507155 is a NA study that has completed, run by Genomind. The registered enrollment target is 685 participants.
The verdict
NCT01507155, a NA study, has completed, sponsored by Genomind.
- COMPLETED
- Registry status
- NA
- Development phase
- 685 participants
- Enrollment target
Study Summary
Genomind has developed and introduced a battery of genetic tests, the Genecept Assay, which clinicians can administer to patients using a simple saliva sample technique. The present study proposes to enroll 1. Subjects (patients who have consented to using the Genecept Assay) and 2. Clinician study participants (clinicians who have ordered the Assay on behalf of their patients). This study will involve the collection of responses from both Subjects and clinician study participants with the intention of correlating this information to Subject genetic data.
Interventions
- DEVICE Genecept Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 685 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01507155
The ClinicalTrials.gov registry entry for NCT01507155 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 685 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genomind, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genecept Assay is the first listed.
NCT01507155 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01507155 about?
NCT01507155 is a clinical study titled "An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay". Genomind has developed and introduced a battery of genetic tests, the Genecept Assay, which clinicians can administer to patients using a simple saliva sample technique. The present study proposes to enroll 1. Subjects (patients who have consented to using the Genecept Assay) and 2. Clinician study ...
What is the current status of trial NCT01507155?
This trial is currently completed. It is a NA study. The enrollment target is 685 participants. The study started on 2013-04. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01507155?
The interventions under investigation include: Genecept Assay (DEVICE).
Who is sponsoring clinical trial NCT01507155?
This trial is sponsored by Genomind, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.